COMPARATIVE ANALYSIS OF VASCULARIZATION DEGREE OF HEPATOCELLULAR CARCINOMA AND FOCAL NODULAR HYPERPLASIA OF THE LIVER ACCORDING TO COMPUTED TOMOGRAPHY AND MORPHOLOGICAL STUDIES

Cover Page
  • Authors: Tumanova U.N.1, Karmazanovskii G.G.2, Dubova E.A.3, Shchegolev A.I.3
  • Affiliations:
    1. Vishnevsky Institute of Surgery, Russian Ministry of Healthcare, Moscow, Russian Federation Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perina-tology, Russian Ministry of Healthcare, Moscow, Russian Federation
    2. Vishnevsky Institute of Surgery, Russian Ministry of Healthcare, Moscow, Russian Federation
    3. Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perina-tology, Russian Ministry of Healthcare, Moscow, Russian Federation
  • Issue: Vol 68, No 12 (2013)
  • Pages: 9-15
  • Section: ONCOLOGY: CURRENT ISSUES
  • URL: https://vestnikramn.spr-journal.ru/jour/article/view/102
  • DOI: https://doi.org/10.15690/vramn.v68i12.854
  • Cite item

Abstract


A comparative analysis of vascularization degree of hepatocellular carcinoma and focal nodular hyperplasia of the liver according to the multislice computed tomography and histological study of tissue is presented. It was established that computed tomography with bolus contrast enhancement allows to study the characteristics of blood supply of the liver and focal formations. Frequently only the use of this method helps to evaluate specific morphological structure of tumors - hepatocellular carcinoma or focal nodular hyperplasia. As an additional differential diagnostic feature is recommended to increase the density determination of tissue formation in the arterial phase computed tomography study. The maximum of vascularization by computed tomography and immunohistochemistry (with antibodies CD34) are installed in a tissue of highly differentiated hepatocellular carcinoma.


U. N. Tumanova

Vishnevsky Institute of Surgery, Russian Ministry of Healthcare,
Moscow, Russian Federation
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perina-tology, Russian Ministry of Healthcare, Moscow, Russian Federation

Author for correspondence.
Email: u.n.tumanova@gmail.com

Russian Federation clinical physician of the Department of Imaging methods of Diagnosis and Treatment of FSBI “A.V. Vishnevskii Surgery Institute”, junior research scientist of the 2nd Department of Morbid anatomy of FSBI “V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology”. Address: 27, B. Serpukhovskaya Street, Moscow, RF, 117997; tel.: +7 (495) 237-37-64

G. G. Karmazanovskii

Vishnevsky Institute of Surgery, Russian Ministry of Healthcare,
Moscow, Russian Federation

Email: karmazanovsky@ixv.ru

Russian Federation PhD, professor, Head of the Department of Imaging methods of Diagnosis and Treatment of FSBI “A.V. Vishnevskii Surgery Institute”. Address: 27, B. Serpukhovskaya Street, Moscow, RF, 117997; tel.: +7 (495) 237-37-64

E. A. Dubova

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perina-tology, Russian Ministry of Healthcare, Moscow, Russian Federation

Email: e_dubova@oparina4.ru

Russian Federation MD, senior research scientist of the 2nd Department of Morbid anatomy of FSBI “V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology”. Address: 4, Akad. Oparin Street, Moscow, RF, 117997; tel.: +7 (495) 438-28-92

A. I. Shchegolev

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perina-tology, Russian Ministry of Healthcare, Moscow, Russian Federation

Email: ashegolev@oparina4.ru

Russian Federation PhD, professor, Head of the 2nd Department of Morbid anatomy of FSBI “V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology”. Address: 4, Akad. Oparin Street, Moscow, RF, 117997; tel.: +7 (495) 438-28-92

  1. Sharma S., Sharma M.C., Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005; 46 (5): 481-489.
  2. Francis I.R., Cohan R.H., McNulty N.J., Platt J.F., Korobkin M., Gebremariam A., Ragupathi K.I. Multidetector CT of the liver and hepatic neoplasms: effect of multi-phasic imaging on tumor conspicuity and vascular enhancement. Am. J. Roentgenol. 2003; 180 (5): 1217-1224.
  3. Kim Y., Stolarska M.A., Othmer H.G. The role of the microenvironment in tumor growth and invasion. Prog. Biophys. Mol. Biol. 2011; 106 (2): 353-379.
  4. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nature Reviews Drug Discovery 2007; 6 (4): 273-286.
  5. Karmazanovskii G.G. Spiral computed tomography with bolus con-contrast sub- gain in abdominal surgery. Part 1. Preoperative di-agnostic. Med. vizualizatsiya = Medical visualization. 2004; 2: 1–25.
  6. Quaia E., D’Onofrio M., Palumbo A., Rossi S., Bruni S., Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur. Radiol. 2006; 16 (7): 1599-1609.
  7. Shinmura R., Matsui O., Kadoya M., Kobayashi S., Terayama N., Sanada J., De-machi H., Gabata T. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur. Radiol. 2008; 18 (9): 1918-1924.
  8. Grazioli L., Morana G., Kirchin M.A., Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology. 2005; 236 (1): 166-177.
  9. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42 (5): 1208-1236.
  10. Colombo M., Raoul J.L., Lencioni R., Galle P.R., Zucman-Rossi J., Bañares R., See-hofer D., Neuhaus P., Johnson P. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. Eur. J. Gastroenterol. Hepatol. 2013; 25 (6): 639-651.
  11. Wong T.C., Lo C.M. Resection strategies for hepatocellular carcinoma. Semin. Liver Dis. 2013; 33 (3): 273-281.
  12. Theise N.D., Curado M.P., Franceschi S., Hytiroglou P., Kudo M., Park Y.N., Saka-moto M., Torbenson M., Wee A. Hepatocellular carcinoma. WHO classification of tumours of the digestive system. Eds. Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. Lyon: IARC, 2010; 205-216
  13. Yu De-cai, Chen Jun, Sun Xi-tai, Zhuang Lin-yuan, Jiang Chun-ping, Ding Yi-tao Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer. 2010; 10: 435.
  14. Albrecht T., Blomley M., Bolondi L., Claudon M., Correas J.M., Cosgrove D., Greiner L., Jäger K., Jong N.D., Leen E., Lencioni R., Lindsell D., Martegani A., Solbiati L., Thorelius L., Tranquart F., Weskott H.P., Whittingham T.; EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall. Med. 2004; 25 (4): 249-256.
  15. Ma X., Samir A.E., Holalkere N.-S., Sahani D.V. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT. Am. J. Roentgenol. 2008; 191 (3); 772-777.
  16. Silva A.C., Evans J.M., McCullough A.E., Jatoi M.A., Vargas H.E., Hara A.K. MR Imaging of hypervascular liver masses: A review of current techniques. Radio Graph-ics. 2009; 29 (2): 385-402.
  17. Paulson E.K., McDermott V.G., Keogan M.T., DeLong D.M., Frederick M.G., Nel-son R.C. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology. 1998; 206 (1): 143-150.
  18. Albiin N. MRI of focal liver lesions. Current Medical Imaging Reviews. 2012; 8 (2): 107-116.
  19. Gaiani S., Celli N., Piscaglia F., Cecilioni L., Losinno F., Giangregorio F., Mancini M., Pini P., Fornari F., Bolondi L. Usefulness of contrastenhanced perfusional sono-graphy in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J. Hepatol. 2004; 41 (3): 421-426.
  20. Lin M.C., Tsay P.K., Ko S.F., Lui K.W., Tseng J.H., Hung C.F., Hsueh C., Wan Y.L. Triphasic dynamic CT findings of 63 hepatic focal nodular hyperplasia in 46 patients: Correlation with size and pathological findings. Abdom. Imaging. 2008; 33 (3): 301-307.
  21. Luo W., Numata K., Morimoto M., Kondo M., Takebayashi S., Okada M., Morita S., Tanaka K. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology. 2009; 251 (1): 287-295.
  22. Kin M., Torimura T., Ueno T. Inuzuka S, Tanikawa K. Sinusoidal capillarization in small hepatocellular carcinoma. Pathol. Int. 1994; 44 (10-11): 771-778.
  23. Nakashima Y., Nakashima O., Hsia C.C., Kojiro M., Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver. 1999; 19 (1): 12-18.
  24. Tanaka S., Kitamura T., Fujita M., Nakanishi K., Okuda S. Color Doppler flow imaging of liver tumors. Am. J. Roentgenol. 1990; 154 (3): 509-514.
  25. Jang H-J., Lim H.K., Lee W.J. Kim S.H., Kim M.J., Choi D., Lee S.J., Lim J.H. Fo-cal Hepatic Lesions: Evaluation with contrast enhanced gray scale harmonic US. Korean J. Radiol. 2003; 4 (2): 91-100.

Views

Abstract - 23

PDF (Russian) - 18

Cited-By


PlumX



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies